Skip to content

Author

Niharika R. Samala

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Saroglitazar improves hepatic steatosis and liver enzymes in women with polycystic ovary syndrome and MASLD: A multicenter, double-blind, placebo-controlled study.

BACKGROUND AND AIMS Polycystic ovary syndrome (PCOS) is the leading endocrine disorder in reproductive-age women. Metabolic dysfunction-associated steatotic liver disease (MASLD) is common in women with PCOS, but they are underrepresented in MASLD therapeutic trials. We evaluated the safety and efficacy of saroglitazar...

Niharika R. Samala, J. González-González, Robert A. Jenders et al. · 0 citations
Open access Sep 2026

Role of IFNL4 Genotype in Hepatic Inflammation and Fibrosis due to Metabolic Dysfunction-Associated Steatotic Liver Disease

Background and Aims: In patients infected with hepatitis C virus, genetic polymorphisms within or near the interferon lambda 4 gene (IFNL4) predict the risk of hepatic inflammation and fibrosis. Several studies have reported that these polymorphisms are also associated with inflammation and fibrosis in patients with fa...

Callie J. Zaborenko, Aaron Hakim, Tae-Hwi Schwantes-An et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.